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Abstract
Introduction: Primary actinomycosis of the parotid gland is a 
rare infectious disease which can mimic a malignant process both 
clinically and diagnostically.
Case report: We present a case report of actinomycosis of the parotid 
gland manifesting as a slowly growing tumor in the left neck region.
Methods: Computer tomography, histopathologic examination
Results: Total sialoadenectomy. Confirmed diagnosis of 
actinomycosis. Patient introduced to an infectious disease 
specialist.
Conclusion: Although this location of actinomycosis is rare, the 
disease must be considered in the differential diagnosis of parotid 
gland tumors.
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Introduction
Actinomycosis is a bacterial infection caused by 
Gram positive, branching filamentous bacilli of 
Actinomyces family. The course of the disease is 
subacute or chronic suppurative – the character-
istic granulomatous inflammation initially forms 
abscesses which later result in fistulae or sinus 
tracts involving adjacent tissues. (1) The most 
common causative agent is Actinomyces israelii, a 
saprophyte usually colonazing oral cavity, gastro-
intestinal tract and vagina in humans. (2)
Under normal conditions the susceptibility to actin-
omycosis is low but exogenous or endogenous 
factors compromising host’ s anatomical barriers 
and local immunity (such as surgical interventions, 
trauma or foreign bodies) could induce pathogenic 
activity of the microorganism. (3)
Actinomycosis occurs with higher prevalence rates 
in geographic areas of low socioeconomic status. 
For unkown reason the disease is more common 
in men as male to female ratio is 3:1. Age range 
includes patients from 20 to 50 years old – immu-
nocompetent and immunocompromised.
Three basic forms of the disease are classified as 
follows – cervicofacial (50–70 %), thoracic (15-
20%) and abdominopelvic (10-15%). (1)
Cervicofacial actinomycosis, the most common 
clinical form, is Well described in the literature. (1) 
However, the reported cases concerning its location 
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in the parotid gland remain few.
Case report
A 65- year old male patient was admitted to Otorhi-
nolaryngology department of University special-
ized hospital for active treatment in oncology, Sofia 
for the first time in May 2020. He presented with 
gradually progressing swelling in left neck region 
dating from January 2020. Physical examination 
showed formation with maximum diameter 5-6 
cm, well circumscribed and palpatory mobile. The 
patient did not report any painful or tingling sensa-
tions related to the tumor.
Methods
CT scan revealed a solid calcified tumor locat-
ed in lower third of the left parotid gland which 
enhanced its densitometric features after admin-
istration of contrast. Right parotid gland, sub-
mandibular glands bilaterally, pharynx and larynx 
– reserved anatomic structure. Enlarged lymph 
nodes were not identified. Clinical suspicion of 
malignancy imposed the performance of total 
sialoadenectomy. Operative material consisted of 
a tumor 5 x 2 cm affecting parotid gland tail and 
deep part. After lymph node dissection in second 
and third neck segment the main resectate was sent 
for histopathologic examination.
Microscopic slides revealed abundant inflammato-
ry infiltrate composed of lymphocytes, neutrophils, 
giant cells and fibroblasts resulting in the formation 
of a granuloma. (fig. 1) The specific bacterial col-
onies are seen as intensely basophilic clumps with 
irradiating filamentous eosinophilic borders when 
stained with hematoxylin – eosin (HE). (fig. 2) 
Examined lymph nodes showed normal histologic 
structure.
Results
In the presented case report the patient had neither 
identified risk factors, nor an immunocompromised 
state. After successful surgical removal of the 
tumor a consultation with infectious
disease specialist was performed.
Discussion
The earliest cases of parotid gland actinomyco-
sis were reported by Leonarmant in 1913; Beck 
in 1922 and Laca – 1961. A few years later – in 
1973 Hopkins conducted a detailed review of his 
scientific results in relation to the disease. (5) Con-
sidered a rare infection nowadays, actinomycosis 
should not be excluded from the differential diag-
nosis of parotid glands tumors. (6)
Actinomyces israelii is a commensial microorgan-
ism inhabiting tonsillar crypts, dental caries and 
plaques, periodontal space. (1,6) Predisposing fac-
tors for cervicofacial actinomycosis are processes 
causing disruption of anatomical barriers such as 
traumas, surgical interventions or dental proce-
dures. (5) Due to the relatively low virulence of 
Actinomyces israelii co-pathogenic bacterial flora 
producing toxins and enzymes is required in order 
to compromise local immune response. Aggre-
gatibacter actinomycetemcomitans, Peptostrepto-
coccus, Prevotella, Fusobacterium, Bacteroides, 
Staphylococcus, Streptococcus, Enterobacteriaceae 
are the most common co-pathogens. (7,10) Acti-
nomycosis is considered mainly an endogenous 
infection – possible route of bacterial spread could 
be in retrograde direction trough Stensens’s duct 
(primary actinomycosis); from adjacent tissues 
(secondary actinomycosis) or in rare cases trough 
hematogenous dissemination. (5)
Clinical presentation of the disease does not differ 
significantly from that in other locations of cer-
vicofacial actinomycosis. (8) It debutes as well 
defined, firm mass (abcess) usually involving the 
submandibular or perimandibular region; over time 
fluctuation appears and multiple sinus tracts are 
formed draining exudate with “sulphur granules” 
– bacterial colonies. Overlying skin could be ery-
thematous. Pain syndrome, facial nerve involve-
ment and neck lymphadenopathy are not usual. (7) 
Imaging studies such as computer tomography and 
echography reveal the presence of poorly defined 
masslike lesion invading surrounding tissues – 
features raising suspicion of possible malignancy. 
(5,6) Definitive diagnosis could be made after 
identification of the characteristic bacterial colo-
nies (sulphur granules) in cytological, histological 
samples or after microbiological examination. (9)
Differential diagnosis of painless parotid tumor 
like lesions should include other nosological enti-
ties presented in table 1.
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Tabl. 1. Differential diagnosis of  painless tumor like 
lesions of  the parotid gland
1. Neoplasms:
•  Benign- pleomorphic adenoma, Warthin tumor, 
facial nerve schannoma



















Treatment consists of antimicrobial therapy with 
drug of choice Penicillin G or alternative – mac-
rolide. (7) In some cases clinically important co-in-
fecting bacteria are targeted with another specific 
antibiotic. (10) Standard duration of the therapy 
is 6 to 12 months but variations are possible when 
considering individual clinical course. Surgery can 
be adjunctive in selected cases – those with formed 
abscesses and fistulas. (11) Possible complications 
of the untreated infection are osteomyelitis, brain 
abscesses, chronic meningitis, hepatic actinomyco-
sis and polyorgan deficiency due to dissemination.
Conclusion 
Although considered a relatively rare infection, 
actinomycosis should not be neglected as diagno-
sis. Differentiation from a true malignant process 
is crucial for adequate treatment. Prognosis of the 
disease is positive and prevention consists of main-
taining proper oral hygiene.
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